NYSE: BMY

Price$55.77 Change -0.59 %Change -1.05% Volume: 7,623,059 20 minute delay March 23, 2017

SEC Filings

Date Filing Description Download
Mar 23, 2017 DEF 14A Proxy Statement (definitive)
Mar 23, 2017 DEFA14A Additional Proxy Soliciting Materials (definitive)
Mar 23, 2017 8-K Current report filing
Mar 22, 2017 4 Statement of Changes in Beneficial Ownership
Mar 21, 2017 4 Statement of Changes in Beneficial Ownership
Mar 16, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 14, 2017 4 Statement of Changes in Beneficial Ownership
Mar 08, 2017 8-K Current report filing
Mar 07, 2017 4 Statement of Changes in Beneficial Ownership
Mar 01, 2017 4 Statement of Changes in Beneficial Ownership
Mar 01, 2017 4 Statement of Changes in Beneficial Ownership
Feb 27, 2017 8-K Current report filing
Feb 23, 2017 4 Statement of Changes in Beneficial Ownership
Feb 23, 2017 4 Statement of Changes in Beneficial Ownership
Feb 23, 2017 4 Statement of Changes in Beneficial Ownership
Feb 23, 2017 3 Initial Statement of Beneficial Ownership
Feb 23, 2017 3 Initial Statement of Beneficial Ownership
Feb 23, 2017 3 Initial Statement of Beneficial Ownership
Feb 23, 2017 424B5 Prospectus filed pursuant to Rule 424(b)(5)
Feb 22, 2017 FWP Free Writing Prospectus - Filing under Securities Act Rules 163/433
Feb 22, 2017 424B3 Prospectus filed pursuant to Rule 424(b)(3)
Feb 21, 2017 10-K Annual Report
Feb 21, 2017 8-K Current report filing
Feb 10, 2017 NO ACT Public response to a specific request for staff views regarding the federal securities laws or SEC rules, regulations or orders
Feb 10, 2017 SC 13G/A Amended Statement of Ownership
Feb 09, 2017 SC 13G/A Amended Statement of Ownership
Feb 03, 2017 5 Annual Statement of Changes in Beneficial Ownership
Feb 03, 2017 4 Statement of Changes in Beneficial Ownership
Feb 03, 2017 4 Statement of Changes in Beneficial Ownership
Feb 03, 2017 4 Statement of Changes in Beneficial Ownership
Feb 03, 2017 4 Statement of Changes in Beneficial Ownership
Feb 03, 2017 4 Statement of Changes in Beneficial Ownership
Feb 03, 2017 4 Statement of Changes in Beneficial Ownership
Feb 03, 2017 4 Statement of Changes in Beneficial Ownership
Feb 03, 2017 4 Statement of Changes in Beneficial Ownership
Feb 03, 2017 4 Statement of Changes in Beneficial Ownership
Feb 03, 2017 4 Statement of Changes in Beneficial Ownership
Feb 01, 2017 4 Statement of Changes in Beneficial Ownership
Jan 26, 2017 NO ACT Public response to a specific request for staff views regarding the federal securities laws or SEC rules, regulations or orders
Jan 26, 2017 8-K Current report filing
Jan 19, 2017 SC 13G/A Amended Statement of Ownership
Jan 05, 2017 4 Statement of Changes in Beneficial Ownership
Jan 04, 2017 4 Statement of Changes in Beneficial Ownership
Jan 04, 2017 4 Statement of Changes in Beneficial Ownership
Jan 04, 2017 4 Statement of Changes in Beneficial Ownership
Jan 04, 2017 4 Statement of Changes in Beneficial Ownership
Jan 04, 2017 4 Statement of Changes in Beneficial Ownership
Jan 04, 2017 4 Statement of Changes in Beneficial Ownership

Materials on this website may contain information about the Company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents are available from the Securities and Exchange Commission, the Bristol-Myers Squibb website or from Bristol-Myers Squibb Investor Relations.

In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change, whether as a result of new information, future events or otherwise. Consequently, the company will not update the information contained on the website and investors should not rely upon the information as current or accurate after the presentation date. The website may also contain certain non-GAAP financial measures, adjusted to include certain costs, expenses, gains and losses and other specified items. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com.